Advertisement
PW Medtech Group Limited

PW Medtech Group Limited (1358.HK) Stock Competitors & Peer Comparison

See (1358.HK) competitors and their performances in Stock Market.

1358.HKHKSE
HealthcareMedical - Instruments & Supplies
HK$1.17
HK$0.01(0.85%)
Hong Kong Market opens in 7h 47m
Advertisement

Peer Comparison Table: Medical - Instruments & Supplies Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
1358.HKHK$1.17-0.85%1.7B16.86HK$0.07+8.22%
2276.HKHK$42.02-0.57%20.7B30.47HK$1.39+0.80%
1066.HKHK$3.35-1.76%15.6B8.77HK$0.40+4.98%
6699.HKHK$72.70+1.47%12.2B53.06HK$1.34+8.34%
9997.HKHK$9.20+0.44%10.8B17.69HK$0.52N/A
3600.HKHK$5.98+1.36%5.4B9.05HK$0.64+4.44%
1501.HKHK$31.82-3.87%5.3B22.16HK$1.46+0.80%
6929.HKHK$4.29+2.14%3.6B10.80HK$0.40+3.47%
1120.HKHK$0.80+17.65%289.7M15.00HK$0.05N/A
1134.HKHK$0.34-5.56%170M-11.33-HK$0.03N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

1358.HK vs 2276.HK Comparison June 2026

1358.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 1358.HK stands at 1.7B. In comparison, 2276.HK has a market cap of 20.7B. Regarding current trading prices, 1358.HK is priced at HK$1.17, while 2276.HK trades at HK$42.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

1358.HK currently has a P/E ratio of 16.86, whereas 2276.HK's P/E ratio is 30.47. In terms of profitability, 1358.HK's ROE is +0.02%, compared to 2276.HK's ROE of +0.21%. Regarding short-term risk, 1358.HK is less volatile compared to 2276.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 1358.HK.Check 2276.HK's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions